This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ARMANI Trial - Ramucirumab + Paclitaxel as Switch Maintenance vs. Continuation of Oxaliplatin-Based Chemo in Patients With Advanced HER2- GC/GEJC"

103 views
June 10, 2024

Chapters

ARMANI Trial Overview & Objectives

00:00

Results: PFS, OS & Safety Profile

02:24

Comments 0
Login to view comments. Click here to Login